New Template For Substantial Modification Of EU MDR Clinical Investigations
Executive Summary
A new pan-EU template offers a means of communicating substantial changes to MDR clinical investigations pending the launch of the Eudamed database. However, users still need to keep an eye on national requirements as well.
You may also be interested in...
European Regulatory Roundup, November 2021: Eudamed Dominates News
Updates and speculation surrounding the Eudamed medtech database has attracted significant attention in November. It was also an impactful month for IVDR news too, and for moves strengthening the medtech and pharma interface.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.